1. health and fitness

Neuroendocrine
Carcinoma Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
sales@futuremarketinsights.com
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: hari.t@futuremarketinsights.com




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Neuroendocrine tumors (NETs) are malignant tumors that originate in endocrine cells and
targets digestive tract that misbalances hormonal release. Neuroendocrine tumors are
three types which include Pheochromocytoma, Merkel cell cancer, and neuroendocrine
carcinoma. Neuroendocrine cells also present in the neuroendocrine system that includes
pituitary gland, pineal gland, thyroid gland, parathyroid and adrenal glands. Physiological
changes in the neuroendocrine cells may cause formation of two types of tumors–
functional and nonfunctional tumors. Functional tumors develop another endocrine cells
and nonfunctional tumors may cause physiological changes and based on the cause it
treated. Neuroendocrine carcinoma are classified in two categories namely carcinoids
and pancreatic endocrine tumors.
Carcinoid tumors, originating in the neuroendocrine system, usually appear in the
digestive system i.e. in stomach and appendix. Besides, some carcinoid tumors develop in
other organs such as lungs, thymus and ovaries. Due to their gradual growth, the
symptoms of neuroendocrine carcinoma are not visible at early stages and are discovered
only during undergoing an unrelated surgery. Tumors originating in the pancreas are
named depending on the type of hormone released. For example, a tumor called
gastrinoma is a tumor that release gastrin which results in excessive secretion of gastric
acid.
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1278
Report
Description
Report Description
Surgery is the first line therapy for removing affected neuroendocrine cells, thereafter,
medication is used for treating neuroendocrine carcinoma. Sunitinib and Afinitor drugs
are commonly used drugs for treatment of neuroendocrine carcinoma treatment.
Immune system suppression and exposure to arsenic are the major risk factors for
neuroendocrine carcinoma.
Neuroendocrine Carcinoma Market: Drivers and Restraints
Significant increase in funding for treatment of cancer by various international
organizations such as American Cancer Academy and world Health Organization is
expected to boost overall neuroendocrine carcinoma treatment market. Furthermore,
significant increase in healthcare spending along with high prevalence rate of
neuroendocrine carcinoma in developing region is expected to boost overall
neuroendocrine carcinoma market. Though market is expected to witness healthy
growth, lack of skilled healthcare professional and lower adoption of advanced treatment
technologies in the developing economies are key restrains for neuroendocrine
carcinoma market.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1278
Neuroendocrine Carcinoma Market: Segmentation
Neuroendocrine Carcinoma market further segmented into followingtype.
Report
Description
Report Description
By Treatment
• Surgery
• Medication
• Anti-metabolite
• Platinum derivatives
• Topoisomerase inhibitor
• Anthracycline antibiotic
By End User
• Hospital
• Clinics
• Drug store
• Pharmacies
Neuroendocrine Carcinoma Market: Overview
Neuroendocrine tumors (NETs) are malignant tumors that originate in endocrine cells and
targets digestive tract that misbalances hormonal release. The market is expected to
witness healthy CAGR during the forecast period.
Report
Description
Report Description
Browse full report: http://www.futuremarketinsights.com/reports/neuroendocrinecarcinoma-market
Neuroendocrine Carcinoma Market: Region- wise Outlook
The global Neuroendocrine Carcinoma Market is expected to register a impressive CAGR
over the forecast period. Depending on geographic regions, global neuroendocrine
carcinoma market is segmented into seven key regions: North America, South America,
Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East &
Africa
North America dominates the global neuroendocrine carcinoma market owing to
presence of modern healthcare amenities along with significant healthcare expenditure
in these regions. Europe occupies second place in this market with its new regulations in
the major economies. Asia also shows a healthy growth rate in this market.
Neuroendocrine Carcinoma Market: Key Players
Some of the key players in this market include
• Novartis AG
• F. Hoffman La Roche
• Callisto Pharmaceuticals
• Eli Lilly & Company
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705